Handling missing covariates in observational studies: An illustration with the assessment of prognostic factors of survival outcomes in sarcoma in irradiated fields (SIF).

Authors

null

Noémie Huchet

Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France

Noémie Huchet , Nicolas Penel , Sylvie Bonvalot , Juliette Thariat , Francoise Ducimetiere , Antoine Giraud , Maud Toulmonde , Axel Le Cesne , Simone Mathoulin-Pélissier , Jean-Yves Blay , Carine A. Bellera

Organizations

Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France, Department of Medical Oncology, Centre Oscar Lambret, Lille, France, Institut Gustave Roussy, Villejuif, France, Centre François Baclesse, Caen, France, Centre Léon-Bérard, Lyon, France, Institut Bergonié, Bordeaux, France, Institut Bergonié, Department of Medical Oncology, Bordeaux, France, INSERM CIC 14.01, Clinical Epidemiology Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, Bordeaux, France, Centre Léon Bérard, Lyon, France, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France

Research Funding

No funding received

Background: Missing covariates are common in observational research. They can result in biased estimations and loss of power to detect associations. Limited data regarding prognostic factors of survival outcomes of SIF are available. We assessed prognostic factors of overall (OS), progression-free (PFS) and metastatic- progression-free (MPFS) survivals in SIF using 3 methods to account for missing covariates. Methods: We relied on the NETSARC database of the French Sarcoma Group: Cox models for OS/PFS and competitive hazard survival models for MPFS. Prognostic factors investigated were age, sex, tumor characteristics (histology, size, depth, grade), metastasis, surgery, surgical resection, expertise of the surgeon (NETSARC/other), pre-surgical imaging (Y/N) and neoadjuvant treatment. To account for missing covariates, we used multiple imputation (MI) by fully conditional specification (Bartlett 2015). The observed data are used to estimate the missing covariate and subsequently replace (impute) the missing value by that estimate. With the “missing-data modality” alternative approach, a category “missing” was created (e.g. yes/no/missing). With the “complete-case” alternative approach, analysis was restricted to patients with all covariates available. Results: Among the 504 patients, 169 had all covariates available (33%). Rate of missing data was greater than 20% for imaging, neoadjuvant treatment, and surgical resection. In the complete-case analysis (N = 169), factors associated with OS included R1/R2 (vs R0) surgical resection (p = 0.03). In opposite, MI (N = 504) revealed an association with metastasis (p = 0.03), and a time-varying effect for surgical resection (p < 0.001), with a risk increasing over time for R1/R2 vs R0). For PFS and MI, associated factors included higher grade and ungradable tumors (p = 0.002) and R1/R2 vs R0 resection (p < 0.001), not found with the complete-case analysis. For MPFS and MI, factors included metastasis (p = 0.03), higher grade tumor (p = 0.007) and R1/R2 resection (p = 0.001). Grade and resection were not found in the complete-case analysis. The missing-data modality led to slight differences with MI, including significant association due to missing covariate (e.g. tumors with size missing associated with shorter PFS). Conclusions: We identified prognostic factors of survival outcomes for SIF. The complete-case analysis led to reduced statistical power and population was non-representative of the full sample, introducing bias. In non-randomized studies, as the outcome may be related to variables with missing values, the missing-data modality method will typically result in biased estimates. Appropriate statistical methods for missing covariates, such as MI, should be considered in particular for observational studies.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11558)

DOI

10.1200/JCO.2022.40.16_suppl.11558

Abstract #

11558

Poster Bd #

462

Abstract Disclosures

Similar Abstracts

Abstract

2022 ASCO Annual Meeting

Metastasectomy in synovial sarcoma: A systematic review.

First Author: Bader Alshamsan

First Author: Sameh Hany Emile

First Author: Prantik Das